OTC Market Is Not Largely Impacted by Recession; However, Prominent Growth Remains Only in Some Categories, Accordin... ( LITTLE FALLS N.J. July 15 /- Th...)

HOME >> MEDICINE >> NEWS

OTC Market Is Not Largely Impacted by Recession; However, Prominent Growth Remains Only in Some Categories, According to Kline

Date:7/15/2009

LITTLE FALLS, N.J., July 15 /PRNewswire/ -- The overall OTC market grew 3.2% during non-recession years and only 1.2% during recessions according to the latest research Impact of Recessions on the U.S. OTC Market from worldwide consulting and research firm Kline & Company.

The impact of recessions on the OTC market mainly comes from erosion of branded OTC sales by private-label products and is reflected in slower growth rates. The level of erosion varies by product classes and categories. However, Rx-to-OTC switches, major innovations, and new product launches with related promotion that occur during recessions help cancel the effect of private-label erosion.

While overall the U.S. OTC market grows at slower rates than during non-recession periods, private-label OTC medicines outgrow 2007 rates by 5.7% over the same time period.

Sales of Rx-to-OTC switch brands are either not impacted or are less impacted than regular OTC brands by recession. For instance, the Rx-to-OTC switch of Claritin in 2003 only lost 18% of sales to its sales to private-label competitors in the non-recession period, while private-label equivalents of Zyrtec launched in early 2008 seized one-forth of brand sales during 2009, a recession year.

"There is clear evidence that private-label OTCs grow at significant rates during a recession. Consumers did trade down to private label, and branded products lost considerable shared private label, but at the same time, several switch products still did really well as consumers are still willing to pay extra for a product they feel is more innovative and offers more relief," says Laura Mahecha, healthcare industry manager at Kline.

In previous recessionary periods, overall OTC sales declined two years in a row; from 1999 to 2000 overall manufacturers' s
'/>"/>

0

GOOD

Page: 1 2
Related medicine news :

1. Chinas Rheumatoid Arthritis Drug Market Will More than Double by 2013
2. Perrigo Receives FDA Approval to Market Cherry and Cinnamon Flavored Nicotine Lozenges
3. RecoverCare and MedaSTAT USA to Merge, Creating Leading Provider of Wound Care and Bariatric Treatment Solutions for Acute and Post-Acute Care Markets
4. Increasing Diagnosis Rates and Growing Use of Key Agents Such as Pfizers Lyrica Will Drive Eight Percent Annual Growth in the Fibromyalgia Drug Market Through 2018
5. Analysis of Four Large Post-Marketing Surveillance Studies Describe Clinical Effects of Sucrose-Formulated Recombinant Factor VIII
6. Medical Imaging Modality Vendors Should Focus on Innovation and Alliances with Market Leaders, Advises Frost & Sullivan
7. Pioneer Surgical Technology, Inc. Names Thomas J. McLeer as Chief Marketing Officer and General Manager of Spinal Operations
8. Duane Reade Dispenses a Large Dose of Marketing, as it Strengthens its Hometown Connection
9. Connectyx Looks to Establish Market Leadership with MedSync and MedFlash Product Line As Stated During Nationwide Teleconference
10. MarketArt to Enhance Attendee Experience at AAMSE Annual Conference
11. Pharma-Marketer.com: One-Stop Pharmaceutical Marketing Resource

Post Your Comments:

OTC Market Is Not Largely Impacted by Recession; However, Prominent Growth Remains Only in Some Categories, Accordin...( LITTLE FALLS N.J. July 15 /- Th...),Health